ERBB2 and neoplasm: For a total of 26 unique patients, HER2 positivity of the primary tumor was known; this group was further analyzed (Figure 1) for HER2 status comparison between CSF and the primary tumor, and comparison of tumor cell detection between CNSide and conventional cytology (n=26 patients).